The ratings reflect CVS Corp.'s solid position in the favorably regarded drugstore industry and its generally good operating performance. CVS, with almost 5,500 units (pro forma for the acquisition of Eckerd's Southern stores), is the largest chain drug retailer in the U.S. based on store count. Prescriptions, which constitute about 69% of the company's revenues, continue to drive growth and are expected to do well, based on an aging population, greater use of pharmaceuticals in outpatient therapy, and the ongoing development of new drug products. Although Standard&Poor's Ratings Services considers CVS an efficient store operator, the company could be challenged in integrating the Southern Eckerd stores. While the acquisition offers the company leading positions in high-growth areas, the
